Mechanism of syncope in patients with heart disease and negative electrophysiologic test

被引:144
作者
Menozzi, C
Brignole, M [8 ]
Garcia-Civera, R
Moya, A
Botto, G
Tercedor, L
Migliorini, R
Navarro, X
机构
[1] Medtron Iber, Madrid, Spain
[2] Hosp Virgen de las Nieves, Granada, Spain
[3] Hosp Clin Univ, Valencia, Spain
[4] Hosp Gen Valle Hebron, Barcelona, Spain
[5] Medtron Italy, Milan, Italy
[6] Osped S Anna Como, Como, Italy
[7] Osped S Maria Nuova, Dept Cardiol, Reggio Emilia, Italy
[8] Osped Tigullio, Dept Cardiol, I-16032 Lavagna, Italy
关键词
syncope; electrophysiology; arrhythmia; heart diseases; electrocardiography;
D O I
10.1161/01.CIR.0000018125.31973.87
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-In patients with syncope and structural heart disease, syncope is suspected to be attributable to a primary cardiac arrhythmia, but little is known of its mechanism when electrophysiologic study is unremarkable. Methods and Results-We applied an implantable loop recorder in 35 patients with overt heart disease at risk of ventricular arrhythmia, because these were patients with previous myocardial infarction or cardiomyopathy with depressed ejection fraction or nonsustained ventricular tachycardia in whom an electrophysiologic study was unremarkable. During a follow-up of 3 to 15 months, syncope recurred in 6 patients (17%) after a mean of 6+/-5 months; in 3 patients, the mechanism of syncope was bradycardia with long pauses (sudden-onset AV block in 2 cases and sinus arrest in 1 case); in 1 patient, there was stable sinus tachycardia; and in 2 patients, who had chronic atrial fibrillation, there was an increase in ventricular rate. A total of 23 episodes of presyncope were documented in 8 patients (23%): no rhythm variation or mild tachycardia in 12 cases, paroxysmal atrial fibrillation or atrial tachycardia in 10 cases, and sustained ventricular tachycardia in 1 case. No patient died during the study period nor suffered from injury attributable to syncopal relapse. Conclusions-The patients with unexplained syncope, structural heart disease, and negative electrophysiologic study had a favorable medium-term outcome with no case of death and a low recurrence rate of syncope without related injury. The mechanism of syncope was heterogeneous, and ventricular tachyarrhythmia was unlikely.
引用
收藏
页码:2741 / 2745
页数:5
相关论文
共 23 条
[1]   Diagnostic value of history in patients with syncope with or without heart disease [J].
Alboni, P ;
Brignole, M ;
Menozzi, C ;
Raviele, A ;
Del Rosso, A ;
Dinelli, M ;
Solano, A ;
Bottoni, N .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (07) :1921-1928
[2]   Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias - A comparison with patients known to have sustained ventricular tachycardia [J].
Andrews, NP ;
Fogel, RI ;
Pelargonio, G ;
Evans, JJ ;
Prystowsky, EN .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (07) :2023-2030
[3]   Guidelines on management (diagnosis and treatment) of syncope [J].
Brignole, M ;
Alboni, P ;
Benditt, D ;
Bergfeldt, L ;
Blanc, JJ ;
Thomsen, PEB ;
van Dijk, JG ;
Fitzpatrick, A ;
Hohnloser, S ;
Janousek, J ;
Kapoor, W ;
Kenny, RA ;
Kulakowski, P ;
Moya, A ;
Raviele, A ;
Sutton, R ;
Theodorakis, G ;
Wieling, W .
EUROPEAN HEART JOURNAL, 2001, 22 (15) :1256-1306
[4]   Mechanism of syncope in patients with bundle branch block and negative electrophysiological test [J].
Brignole, M ;
Menozzi, C ;
Moya, A ;
Garcia-Civera, R ;
Mont, L ;
Alvarez, M ;
Errazquin, F ;
Beiras, J ;
Bottoni, N ;
Donateo, P .
CIRCULATION, 2001, 104 (17) :2045-2050
[5]   Role of programmed ventricular stimulation and implantable cardioverter defibrillators in patients with idiopathic dilated cardiomyopathy and syncope [J].
Brilakis, ES ;
Shen, WK ;
Hammill, SC ;
Hodge, DO ;
Rea, RF ;
Lexvold, NY ;
Friedman, PA .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2001, 24 (11) :1623-1630
[6]   ELECTROPHYSIOLOGIC EVALUATION AND FOLLOW-UP CHARACTERISTICS OF PATIENTS WITH RECURRENT UNEXPLAINED SYNCOPE AND PRESYNCOPE [J].
DOHERTY, JU ;
PEMBROOKROGERS, D ;
GROGAN, EW ;
FALCONE, RA ;
BUXTON, AE ;
MARCHLINSKI, FE ;
CASSIDY, DM ;
KIENZLE, MG ;
ALMENDRAL, JM ;
JOSEPHSON, ME .
AMERICAN JOURNAL OF CARDIOLOGY, 1985, 55 (06) :703-708
[7]   Improved survival in patients with nonischemic advanced heart failure and syncope treated with implantable cardioverter-defibrillator [J].
Fonarow, GC ;
Feliciano, Z ;
Boyle, NG ;
Knight, L ;
Woo, MA ;
Moriguchi, JD ;
Laks, H ;
Wiener, I .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 85 (08) :981-985
[8]   Is syncope a risk factor for poor outcomes? Comparison of patients with and without syncope [J].
Kapoor, WN ;
Hanusa, BH .
AMERICAN JOURNAL OF MEDICINE, 1996, 100 (06) :646-655
[9]   Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator [J].
Knight, BP ;
Goyal, R ;
Pelosi, F ;
Flemming, M ;
Horwood, L ;
Morady, F ;
Strickberger, SA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (07) :1964-1970
[10]   Use of an extended monitoring strategy in patients with problematic syncope [J].
Krahn, AD ;
Klein, GJ ;
Yee, R ;
Takle-Newhouse, T ;
Norris, C .
CIRCULATION, 1999, 99 (03) :406-410